Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05207059
Other study ID # 2021/2247
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 18, 2022
Est. completion date December 2028

Study information

Verified date October 2023
Source KK Women's and Children's Hospital
Contact Xiang Wen Ng, MPH
Phone +65 6394 8113
Email ng.xiang.wen@kkh.com.sg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to assess whether an integrated continuum of care from the preconception period, across maternity until the first 18 months of life, can promote maternal metabolic and mental health, as well as offspring health, among overweight and obese women.


Description:

Maternal Child Health (MCH) in Singapore is currently entering a new phase to address the twin challenges; a burgeoning (i) Metabolic and (ii) Mental Health Challenge for Singapore which have shown to have adverse effects on childbearing and child outcomes. To tackle these challenges, we are establishing a new Model-of-Care (MOC) with a life-course approach at KK Women's and Children's Hospital (KKH) through the Healthy Early Life Moments in Singapore (HELMS) cohort. Over the course of five years, HELMS will enroll 500 overweight or obese women aged 21-40 years planning for pregnancy, with an estimated 170 completing their pregnancies where they will be followed for another 18 months as a mother-child dyad. HELMS leverages on building a healthy mental model of life-course events through preconception to postpartum life. Components of intervention will focus on preconception-pregnancy-postpartum care and lifestyle guidance on diet, physical activity, emotion and sleep, complemented by health nudges to promote sustainable change. Various questionnaires and testing will be carried out at relevant time points. Biosamples including blood, cord blood and stool will be collected. Through the application of HELMS, there is potential to improve metabolic and mental health, break vicious transgenerational cycles of obesity transmission and promote virtuous life cycles of health in the population.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date December 2028
Est. primary completion date December 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 21 Years to 40 Years
Eligibility Inclusion Criteria: 1. Women aged 21-40 years 2. BMI 25-40 kg/m2 3. Intention to reside in Singapore for the next 4 years 4. Chinese, Malay, Indian or any combination of these 3 ethnic groups 5. Planning to conceive within 1 year 6. Able to understand English 7. Able to provide written, informed consent Exclusion Criteria: 1. Currently pregnant 2. Known type 1 or type 2 diabetes 3. On any anticonvulsant medication in the past 1 month 4. On any oral steroid in the past 1 month (e.g. Prednisolone, Prednisone, Deltasone, Prelone, Methyl Prednisolone, Medrol, Hydrocortisone, Cortef, Dexamethasone, Decadron) 5. On any oral, implanted contraception or intrauterine contraceptive device (IUCD) in situ in the past 1 month 6. On any fertility medication (e.g. hormones injection, IVF treatments) other than Clomiphene/ Letrozole in the past 1 month 7. On HIV or Hepatitis B or C medication in the past 1 month.

Study Design


Intervention

Behavioral:
HELMS Lifestyle Intervention
The HELMS life-course Interventions, namely 4S ('Screening', 'Size', 'Supplementation' and 'Specific case management'), are developed to deliver care throughout the journey from preconception to postpartum periods. Screening involves health and risk assessments through physical and biomarker measurements, as well as emotion and sleep evaluations for mother, and developmental assessment for children. Body Size management encompasses education on weight status awareness and mother-child health implications, both mother-child weight tracking, healthy eating and physical activity guidance. Supplementation includes multi-micronutrient, vitamin D, calcium and/or Docosahexaenoic acid (DHA) supplements, which is phase-specific for mother, and vitamin D drops supplement for child. Specific case management comprises preconception sexual health and function management, pregnancy symptoms management, postpartum recovery management, infant growth monitoring and feeding management.

Locations

Country Name City State
Singapore KK Women's and Children's Hospital Singapore

Sponsors (2)

Lead Sponsor Collaborator
KK Women's and Children's Hospital Lien Foundation

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Other Health economics analysis of the HELMS program Cost benefit analysis from health expenses and diseases outcomes Composite analysis between preconception visit which is up to 12 months before pregnancy and until infant age 18 months
Other Maternal general health and wellbeing From questionnaire, expressed in percentages Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Offspring health and general wellbeing From questionnaire and/or medical records, expressed in percentages Up to 18 months, from birth to infant age 18 months
Other Offspring metabolomic profile From cord blood, placenta, infant blood and/or skin biopsy Up to 18 months, from birth to infant age 18 months
Other Offspring genomic profile From cord blood, placenta, infant blood and/or skin biopsy Up to 18 months, from birth to infant age 18 months
Other Offspring epigenetic profile From cord blood, placenta, infant blood and/or skin biopsy Up to 18 months, from birth to infant age 18 months
Other Offspring biochemical profile From cord blood, placenta, infant blood and/or skin biopsy Up to 18 months, from birth to infant age 18 months
Other Offspring metabolic profile From cord blood, placenta, infant blood and/or skin biopsy Up to 18 months, from birth to infant age 18 months
Other Offspring immunological profile From cord blood, placenta, infant blood and/or skin biopsy Up to 18 months, from birth to infant age 18 months
Other Offspring molecular profile From cord blood, placenta, infant blood and/or skin biopsy Up to 18 months, from birth to infant age 18 months
Other Maternal metabolomic profile From blood, urine and/or saliva samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Maternal genomic profile From blood, urine and/or saliva samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Maternal epigenetic profile From blood, urine and/or saliva samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Maternal temperature Measured by skin temperature sensor, in degree celsius Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Maternal biochemical profile From blood, urine and/or saliva samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Maternal metabolic profile From blood, urine and/or saliva samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Maternal immunological profile From blood, urine and/or saliva samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Maternal molecular profile From blood, urine and/or saliva samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal body weight Measured by weighing scale, in kilograms Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal body weight status Determined by body mass index based on weight (kg) /height (m)2 Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal body fat distribution Determined from waist hip circumferences in centimetres Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal abdominal fat Determined from waist hip circumferences in ratio Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal body composition Determined from body fat analysis in percentages Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal body fat mass Determined from body fat analysis in percentages Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal body lean mass Determined from body fat analysis in percentages Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal body visceral fat Determined from body fat analysis in percentages Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal health and general well-being - self assessment From questionnaires Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal health and general well-being From digital sensor Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal immunological profile From blood and/or urine samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal biochemical profile From blood and/or urine samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal metabolic profile From blood and/or urine samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Paternal molecular profile From blood and/or urine samples Up to 40 months, between preconception, pregnancy and 18 months postpartum
Other Breast milk macronutrient profile (subsample) From breast milk sample Up to 1 year, between date of delivery and 1 year postpartum
Other Breast milk micronutrient profile (subsample) From breast milk sample Up to 1 year, between date of delivery and 1 year postpartum
Other Breast milk immune factor profile (subsample) From breast milk sample Up to 1 year, between date of delivery and 1 year postpartum
Other Breast milk epigenetic profile (subsample) From breast milk sample Up to 1 year, between date of delivery and 1 year postpartum
Other Breast milk biochemical profile (subsample) From breast milk sample Up to 1 year, between date of delivery and 1 year postpartum
Other Breast milk metabolic profile (subsample) From breast milk sample Up to 1 year, between date of delivery and 1 year postpartum
Other Breast milk microbiome profile (subsample) From breast milk sample Up to 1 year, between date of delivery and 1 year postpartum
Other Breast milk molecular profile (subsample) From breast milk sample Up to 1 year, between date of delivery and 1 year postpartum
Other Maternal transcriptomics From blood and/or breast milk samples Up to 36 months, between preconception, pregnancy and 1 year postpartum
Other Infant transcriptomics From blood Up to 36 months, between preconception, pregnancy and 1 year postpartum
Primary Pregnancy rate Defined by positive urine pregnancy test, clinical diagnosis and/or ultrasound scan showing intrauterine gestation sac, in percentages Up to 12 months
Primary Maternal metabolic health Evaluated by metabolic syndrome criteria Up to 40 months, between preconception, pregnancy and 18 months postpartum
Primary Maternal mental health Measured by Edinburgh Postnatal Depression Scale, scored between 0 to 30, with a higher score being suggestive of depression Up to 26 months, between preconception, pregnancy and 4 months postpartum
Secondary Fecundability Measured by time to pregnancy in total discrete cycles at risk of pregnancy Up to 12 months, between dates of last menstrual period at recruitment and before conception (for pregnant women) or last follow-up call (for non-pregnant women)
Secondary Female sexual function Measured by Female Sexual Function Index, with a higher score being suggestive of better sexual function Up to 3 months, between date of recruitment and 3 months preconception follow-up
Secondary Pregnancy loss rate Based on ultrasound scan and medical records, in percentage Up to 42 weeks, between date of conception and date of delivery
Secondary Live birth rates Based on ultrasound scan and medical records, in percentage Up to 42 weeks, between date of conception and date of delivery
Secondary Maternal lipid levels Including total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, in mmol/L Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal glycaemic marker - plasma glucose Measured by plasma glucose levels, in mmol/L Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal glycaemic marker - HbA1c Measured by HbA1c, in percentage Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal glycaemic marker - C-peptide Measured by C-peptide, in SI unit Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal glycaemic markers - Insulin Measured by serum insulin, in SI unit Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal glucose tolerance status Measured by Oral Glucose Tolerance Test (OGTT), in mmol/L Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal blood pressure Measured by blood pressure device for systolic and diastolic pressures in mmHg Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal heart rate Measured by blood pressure device or sensor in beats per minutes Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal body weight Measured by weighing scale in kilograms Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal body weight status Determined by body mass index based on weight (kg) /height (m)2 Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal body fat distribution Determined from waist hip circumferences in centimeters Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal abdominal fat Determined from waist hip circumferences in ratio Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal body composition Determined from body fat analysis in percentages Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal body fat mass Determined from body fat analysis in percentages Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal visceral fat Determined from body fat analysis in volumes Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal body lean mass Determined from body fat analysis in percentages Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal nutrient intake Measured by food diary and/or food frequency questionnaire in SI units of respective nutrients Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal food intake Measured by food diary and/or food frequency questionnaire in serving sizes Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal food intakes Measured by food diary and/or food frequency questionnaire in grams Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal dietary pattern Measured by food diary and/or food frequency questionnaire using factor loading analysis Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal food timing Measured by food diary in time phase Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal eating episodes Measured by food diary in eating frequency Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal dietary behaviour - 6P Measured by 6P Questionnaire based on each factor in the questionnaire Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal dietary behaviour - TFEQ Measured by Three Factor Eating Questionnaire, based on the scores from each category Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal micronutrient status Micronutrient panel from plasma or breastmilk such as 1-carbon metabolites, vitamin D and E, expressed in SI units of respective micronutrients Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal physical activity level - self assessment Measured by International Physical Activity Questionnaire, with a higher score suggesting higher physical activity level Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal physical activity Measured by accelerometer and/or digital sensor, in respective SI units Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal sedentary behaviour - self assessment Measured by sedentary behaviour questionnaire, in hours and minutes per day, with longer duration suggestive of greater sedentary behaviour Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal sedentary behaviour Measured by accelerometer and/or digital sensor, in respective SI units Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal sleep - PSQI Measured by Pittsburgh Sleep Quality Index, scored from 0-21, with higher score suggestive of poor sleep quality Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal sleep Measured by accelerometer and/or digital sensor, in respective SI units Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal emotional wellbeing Measured by questionnaires Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Maternal ocular health Measured by retinal vessel characteristics (including vessel caliber, geometric assessment and vasoreactivity) Up to 21 months, from preconception until 36 weeks gestation
Secondary Maternal ocular health Measured by retinal and choroidal characteristics using three-dimensional volumetric (OCT-A) imaging systems Up to 21 months, from preconception until 36 weeks gestation
Secondary Maternal personality trait Measured by M5-50 questionnaire, with classification into respective personality types At preconception
Secondary Duration of gestation Defined as the length of pregnancy, in months and days Up to 42 weeks, between estimated date of conception from menstrual and ultrasound scan and date of delivery
Secondary Number of participants with gestational diabetes Determined by oral glucose tolerance test during pregnancy Up to 20 weeks, between 12 and 32 weeks gestation
Secondary Number of participants with hypertensive disorders of pregnancy Including pregnancy-induced hypertension and pre-eclampsia/eclampsia from questionnaire and/or retrieved from medical records Up to 42 weeks, between date of conception and date of delivery
Secondary Mode of labour onset, course of delivery and delivery outcomes From questionnaire and/or retrieved from medical records, reported in percentages Delivery
Secondary Maternal pain Measured by pain questionnaire Up to 5 months, between 32 weeks gestation and 6-8 weeks post-delivery
Secondary Antenatal, perinatal and postnatal complications From questionnaire and/or retrieved from medical records, reported in percentages Up to 50 weeks, between date of conception and up to 8 weeks postpartum
Secondary Neonatal complications and admission to neonatal care facilities From questionnaire and/or retrieved from medical records, reported in percentages Up to 4 weeks, between date of delivery and 4 weeks post-delivery
Secondary Offspring body weight Weight measured in grams Up to 18 months, from birth to infant age 18 months
Secondary Offspring body size at birth Adjusted for gestational age and sex, expressed in percentile At birth
Secondary Offspring body length Measured in centimeters Up to 18 months, from birth to infant age 18 months
Secondary Offspring head circumference Measured in centimeters Up to 18 months, from birth to infant age 18 months
Secondary Intrauterine growth of foetus As assessed by antenatal serial ultrasound scans to determine head and abdominal circumference, femur length and estimated foetal weight Up to 30 weeks, between 7 weeks gestation and 37 weeks of gestation
Secondary Offspring feeding Measured types of feeding using questionnaires Up to 18 months, from birth to infant age 18 months
Secondary Offspring gut microbiome Measured from stool samples Up to 18 months, from birth to infant age 18 months
Secondary Maternal gut microbiome Measured from stool samples Up to 24 months, between preconception, pregnancy and 2 months postpartum
Secondary Influence of parental and offspring genotypes, body compositions, lifestyle and diet on the above primary and secondary outcomes Measured by questionnaires, accelerometer, digital sensor and/or biomarkers Up to 40 months, between preconception, pregnancy and 18 months postpartum
Secondary Acceptability and adherence levels From questionnaire, with higher score indicates higher acceptability and adherence Up to 40 months, at preconception, pregnancy and 18 months postpartum
Secondary Satisfactory level of participants with the HELMS program From patient satisfaction questionnaire in a Likert scale, with a higher score suggesting greater satisfaction Up to 40 months, at preconception, pregnancy and 18 months postpartum
See also
  Status Clinical Trial Phase
Completed NCT06188728 - Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05081037 - Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS) N/A
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Not yet recruiting NCT05461144 - AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A
Active, not recruiting NCT05505994 - The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin Phase 3
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Recruiting NCT05711758 - Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
Recruiting NCT05112029 - Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic Females
Recruiting NCT03682640 - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes Phase 2
Completed NCT04854603 - Dairy Products With Reduced Sugar and Blood Glucose N/A
Recruiting NCT06024291 - Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial N/A
Recruiting NCT04904601 - Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects N/A
Recruiting NCT04109586 - Diet and Fat Mass After Traumatic Spinal Cord Injury N/A
Recruiting NCT06009653 - Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity Phase 4
Completed NCT03067012 - Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients N/A
Recruiting NCT03309423 - Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU? N/A